Clinical Features and Long-Term Outcomes of Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis: A Multi-Center Study

PURPOSE: To describe the clinical manifestation, immunotherapy, and long-term outcomes of anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis. PATIENTS AND METHODS: This study was a retrospective analysis of 117 patients with a diagnosis of anti-LGI1 encephalitis identified from the databases...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Shan, Wu, Huai-kuan, Liu, Ling-ling, Wang, Mei-ling, Zhang, Ran-ran, Han, Tao, Liu, Xue-wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846830/
https://www.ncbi.nlm.nih.gov/pubmed/33531809
http://dx.doi.org/10.2147/NDT.S292343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846830/
https://www.ncbi.nlm.nih.gov/pubmed/33531809
http://dx.doi.org/10.2147/NDT.S292343

Ejemplares similares